RxDoctor Payments Data

Christopher Choi, MD

Anesthesiology · Dallas, TXNPI 1184044380

Payments from drug & device makers

What this record shows

Edwards Lifesciences accounts for 72.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $1,022 and has fallen 96.5% since, to $35 in 2023.

$1,183in general payments, 2019–2025

Across 12 payments — averaging $98.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$858
  • Vyaire Medical, Inc.$165
  • CSL Behring$125
  • Abbott$35
$102,167in research payments, 2019–2025

Across 60 payments — averaging $1702.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Dompe Farmaceutici S.p.a.$102K

What the payments were for

  • Travel & lodging$66156%
  • Food & beverage$52244%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences9$858
Vyaire Medical, Inc.1$165
CSL Behring1$125
Abbott1$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,183 in reported general payments places this provider in the 85th percentile of 3,899 anesthesiology providers in Texas.

See all anesthesiology providers in Texas

Medicare billing

Part B allowed, 2024
$34,241
Medicare patients
182
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →